Related Experiment Videos
Biologic agents for the management of hematological disorders: chronic myeloid leukemia
K B McCredie1, M Talpaz, H Kantarjian
1Department of Hematology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Haematology and Blood Transfusion
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer.
Alimentary pharmacology & therapeutics·2016
New Agents and Strategies in CLL Treatment.
Leukemia & lymphoma·2016
Dependence of serum erythropoietin level on erythropoiesis in leukemia.
Haematology and blood transfusion·1990
Complications of bone marrow transplantation in Chinese.
Haematology and blood transfusion·1990
High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.
Haematology and blood transfusion·1990
Heterogeneity in protein patterns of CGL blast crisis cells: discrimination between lymphatic and myeloic lineages.
Haematology and blood transfusion·1990
Treatment Adherence in Haemophilia: Methods of Assessment, Clinical Outcomes, and Real-World Evidence.
Haemophilia : the official journal of the World Federation of Hemophilia·2026
Thrombotic and ischemic event reporting with anticoagulant reversal agents: a multi-agent FAERS pharmacovigilance study.
Journal of thrombosis and thrombolysis·2026
Hand-powered micro-slit-gated microfluidics for concurrent blood typing and hematocrit estimation.
Biosensors & bioelectronics·2026